DNA X, Inc. SONM
$2.99
-$0.03-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -72.00% | -52.95% | -24.31% | 4.17% | -16.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -72.00% | -52.95% | -24.31% | 4.17% | -16.41% |
| Cost of Revenue | 33.44% | -36.16% | -60.48% | -67.82% | -80.70% |
| Gross Profit | -57.09% | -54.42% | -73.63% | -84.87% | -68.36% |
| SG&A Expenses | 248.55% | 799.91% | 74.39% | -125.46% | -126.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 124.87% | 152.62% | 74.39% | -142.01% | -140.51% |
| Operating Income | -314.12% | -536.53% | -74.39% | 116.53% | 138.23% |
| Income Before Tax | -381.73% | -927.47% | -175.93% | 110.66% | 136.57% |
| Income Tax Expenses | -23.08% | -41.56% | -67.74% | -75.81% | -66.67% |
| Earnings from Continuing Operations | -369.77% | -1,064.39% | -175.93% | 111.78% | 136.90% |
| Earnings from Discontinued Operations | 141.78% | -371.53% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.56% | 51.21% | 38.61% | -149.38% | -200.96% |
| EBIT | -314.12% | -536.53% | -74.39% | 116.53% | 138.23% |
| EBITDA | -159.05% | -256.43% | -342.01% | 163.01% | 207.20% |
| EPS Basic | 90.26% | 79.74% | 79.02% | -91.04% | -156.51% |
| Normalized Basic EPS | -134.90% | -237.08% | 18.62% | 145.88% | 148.74% |
| EPS Diluted | 90.27% | 79.74% | 79.02% | -90.98% | -156.10% |
| Normalized Diluted EPS | -134.90% | -237.08% | 18.62% | 145.88% | 148.66% |
| Average Basic Shares Outstanding | 212.33% | 213.66% | 146.57% | 105.56% | 39.66% |
| Average Diluted Shares Outstanding | 212.33% | 213.66% | 146.57% | 105.56% | 38.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |